Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2010

Open Access 01-12-2010 | Case report

Amyotrophic lateral sclerosis-motor neuron disease, monoclonal gammopathy, hyperparathyroidism, and B12 deficiency: case report and review of the literature

Authors: Richard A Rison, Said R Beydoun

Published in: Journal of Medical Case Reports | Issue 1/2010

Login to get access

Abstract

Introduction

Amyotrophic lateral sclerosis (the most common form of motor neuron disease) is a progressive and devastating disease involving both lower and upper motor neurons, typically following a relentless path towards death. Given the gravity of this diagnosis, all efforts must be made by the clinician to exclude alternative and more treatable entities. Frequent serology testing involves searching for treatable disorders, including vitamin B12 deficiency, parathyroid anomalies, and monoclonal gammopathies.

Case presentation

We present the case of a 78-year-old Caucasian man with all three of the aforementioned commonly searched for disorders during an investigation for amyotrophic lateral sclerosis.

Conclusions

The clinical utility of these common tests and what they ultimately mean in patients with amyotrophic lateral sclerosis is discussed, along with a review of the literature.
Literature
1.
go back to reference Bradley WG, Daroff RB, Fenichl GM, Jankovic J: Neurology in Clinical Practice: The Neurological Disorders. 2004, Butterworth Heinemann, 2: 2247. Bradley WG, Daroff RB, Fenichl GM, Jankovic J: Neurology in Clinical Practice: The Neurological Disorders. 2004, Butterworth Heinemann, 2: 2247.
2.
go back to reference Bensimon G, Lacomblez L, Meininger V, the ALS/Riluzole Study group: A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994, 330: 585-591. 10.1056/NEJM199403033300901.CrossRefPubMed Bensimon G, Lacomblez L, Meininger V, the ALS/Riluzole Study group: A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994, 330: 585-591. 10.1056/NEJM199403033300901.CrossRefPubMed
3.
go back to reference Alexianu ME, Ciabarra AM, Latov N: Neuropathies associated with monoclonal gammopathies. MedLink Neurology. Edited by: Gilman S. 2006, San Diego, CA: MedLink Corporation Alexianu ME, Ciabarra AM, Latov N: Neuropathies associated with monoclonal gammopathies. MedLink Neurology. Edited by: Gilman S. 2006, San Diego, CA: MedLink Corporation
4.
go back to reference Kelly JJ, Kyle RA, O'Brien PC, Dyck PJ: Prevalence of monoclonal protein in peripheral neuropathy. Neurology. 1981, 31: 1480-1483.CrossRefPubMed Kelly JJ, Kyle RA, O'Brien PC, Dyck PJ: Prevalence of monoclonal protein in peripheral neuropathy. Neurology. 1981, 31: 1480-1483.CrossRefPubMed
5.
go back to reference Di Saverio A, Quaglino D: Association between motoneuron disease and Waldenstrom macroglobunemia. Recenti Prog Med. 2001, 92: 530-532.PubMed Di Saverio A, Quaglino D: Association between motoneuron disease and Waldenstrom macroglobunemia. Recenti Prog Med. 2001, 92: 530-532.PubMed
6.
go back to reference Patten BM: Neuropathy and motor neuron syndromes associated with plasma cell disease. Acta Neurol Scand. 1984, 70: 47-61. 10.1111/j.1600-0404.1984.tb00802.x.CrossRefPubMed Patten BM: Neuropathy and motor neuron syndromes associated with plasma cell disease. Acta Neurol Scand. 1984, 70: 47-61. 10.1111/j.1600-0404.1984.tb00802.x.CrossRefPubMed
7.
go back to reference Gordon PH, Rowland LP, Younger DS, Sherman WH, Hays AP, Louis ED, Lange DJ, Trojaborg W, Lovelace RE, Murphy PL: Lymphoproliferative disorders and motor neuron disease: an update. Neurology. 1997, 48: 1671-1678.CrossRefPubMed Gordon PH, Rowland LP, Younger DS, Sherman WH, Hays AP, Louis ED, Lange DJ, Trojaborg W, Lovelace RE, Murphy PL: Lymphoproliferative disorders and motor neuron disease: an update. Neurology. 1997, 48: 1671-1678.CrossRefPubMed
8.
go back to reference Younger DS, Rowland LP, Latov N, Hays AP, Lang DJ, Sherman W, Inghirami G, Pesce MA, Knowles DM, Powers J, Miller JR, Fetell MR, Lovelace RE: Lymphoma, motor neuron disease, and amyotrophic lateral sclerosis. Ann Neurol. 1991, 29: 78-86. 10.1002/ana.410290114.CrossRefPubMed Younger DS, Rowland LP, Latov N, Hays AP, Lang DJ, Sherman W, Inghirami G, Pesce MA, Knowles DM, Powers J, Miller JR, Fetell MR, Lovelace RE: Lymphoma, motor neuron disease, and amyotrophic lateral sclerosis. Ann Neurol. 1991, 29: 78-86. 10.1002/ana.410290114.CrossRefPubMed
9.
go back to reference Rowland LP, Defendini R, Sherman W, Hirano A, Olarte MR, Latov N, Lovelace RE, Inoue K, Osserman EF: Macroglobunemia with peripheral neuropathy simulating motor neuron disease. Ann Neurol. 1982, 11: 532-536. 10.1002/ana.410110515.CrossRefPubMed Rowland LP, Defendini R, Sherman W, Hirano A, Olarte MR, Latov N, Lovelace RE, Inoue K, Osserman EF: Macroglobunemia with peripheral neuropathy simulating motor neuron disease. Ann Neurol. 1982, 11: 532-536. 10.1002/ana.410110515.CrossRefPubMed
10.
go back to reference Latov N: Plasma cell dyscrasia and motor neuron disease. Adv Neurol. 1982, 36: 273-279.PubMed Latov N: Plasma cell dyscrasia and motor neuron disease. Adv Neurol. 1982, 36: 273-279.PubMed
11.
go back to reference Shy ME, Rowland LP, Smith T, Trojaborg W, Latov N, Sherman W, Pesce MA, Lovelace RE, Osserman EF: Motor neuron disease and plasma cell dyscrasia. Neurology. 1986, 36: 1429-1436.CrossRefPubMed Shy ME, Rowland LP, Smith T, Trojaborg W, Latov N, Sherman W, Pesce MA, Lovelace RE, Osserman EF: Motor neuron disease and plasma cell dyscrasia. Neurology. 1986, 36: 1429-1436.CrossRefPubMed
12.
go back to reference Rudnicki S, Chad DA, Drachman DA, Smith TW, Anwer UE, Levitan N: Motor neuron disease and paraproteinemia. Neurology. 1987, 37: 335-337.CrossRefPubMed Rudnicki S, Chad DA, Drachman DA, Smith TW, Anwer UE, Levitan N: Motor neuron disease and paraproteinemia. Neurology. 1987, 37: 335-337.CrossRefPubMed
13.
go back to reference Merlini G, Rutigliano L, Masnaghetti S: Neuromuscular disorders associated with monoclonal immunoglobulins (abstract). International Conference on Multiple Myeloma. Biology, Pathophysiology, Prognosis and Treatment: Abstracts. 1989, Bologna, Italy, 215. Merlini G, Rutigliano L, Masnaghetti S: Neuromuscular disorders associated with monoclonal immunoglobulins (abstract). International Conference on Multiple Myeloma. Biology, Pathophysiology, Prognosis and Treatment: Abstracts. 1989, Bologna, Italy, 215.
14.
go back to reference Saito T, Irie S, Ito H, Kowa H: Paraproteinemia and motor neuron disease. Rinsho Shinkeigaku. 1992, 32: 1146-1148.PubMed Saito T, Irie S, Ito H, Kowa H: Paraproteinemia and motor neuron disease. Rinsho Shinkeigaku. 1992, 32: 1146-1148.PubMed
15.
go back to reference Lavrnić D, Vidakovic A, Miletic V, Trikic R, Marinkovic Z, Rakocevic V, Nikolic J, Wirguin I, Sadiq SA, Apostolski S: Motor neuron disease and monoclonal gammopathy. Eur Neurol. 1995, 35: 104-107. 10.1159/000117102.CrossRefPubMed Lavrnić D, Vidakovic A, Miletic V, Trikic R, Marinkovic Z, Rakocevic V, Nikolic J, Wirguin I, Sadiq SA, Apostolski S: Motor neuron disease and monoclonal gammopathy. Eur Neurol. 1995, 35: 104-107. 10.1159/000117102.CrossRefPubMed
16.
go back to reference Hirschberg K: Qur kenntnisse der osseomalacie und ostitis malacissans. Beitr Pathol. 1889, 6: 513-524. Hirschberg K: Qur kenntnisse der osseomalacie und ostitis malacissans. Beitr Pathol. 1889, 6: 513-524.
17.
go back to reference Patten BM, Engel WK: Phosphate and parathyroid disorders associated with the syndrome of amyotrophic lateral sclerosis. Human Motor Neuron Disorders. Edited by: Rowland LP. 1982, New York: Raven Press, 181-200. Patten BM, Engel WK: Phosphate and parathyroid disorders associated with the syndrome of amyotrophic lateral sclerosis. Human Motor Neuron Disorders. Edited by: Rowland LP. 1982, New York: Raven Press, 181-200.
18.
go back to reference Carvalho AA, Vieira A, Simplicio H, Fugygara S, Carvalho SM, Rigueiro MP: Primary hyperparathyroidism simulating motor neuron disease: case report. Arq Neuropsiquiatr. 2005, 63: 160-162.CrossRefPubMed Carvalho AA, Vieira A, Simplicio H, Fugygara S, Carvalho SM, Rigueiro MP: Primary hyperparathyroidism simulating motor neuron disease: case report. Arq Neuropsiquiatr. 2005, 63: 160-162.CrossRefPubMed
19.
go back to reference Rodriguez GE, Califano IM, Alurralde AM, Ercolano M, Silva MC, Sica REP: Amyotrophic lateral sclerosis: it's relationship with thyroid function and phosphate calcium metabolism. Revista de Neurologica. 2003, 36: 104-108. Rodriguez GE, Califano IM, Alurralde AM, Ercolano M, Silva MC, Sica REP: Amyotrophic lateral sclerosis: it's relationship with thyroid function and phosphate calcium metabolism. Revista de Neurologica. 2003, 36: 104-108.
20.
go back to reference Jackson CE, Amato AA, Bryan WW, Wolfe GI, Sakhaee K, Barohn RJ: Primary hyperparathyroidism and ALS: is there a relation?. Neurology. 1998, 50: 1795-1799.CrossRefPubMed Jackson CE, Amato AA, Bryan WW, Wolfe GI, Sakhaee K, Barohn RJ: Primary hyperparathyroidism and ALS: is there a relation?. Neurology. 1998, 50: 1795-1799.CrossRefPubMed
21.
go back to reference Patten BM, Mallette LE: Motor neuron disease: retrospective study of associated abnormalities. Dis Nerv Syst. 1976, 37: 318-321.PubMed Patten BM, Mallette LE: Motor neuron disease: retrospective study of associated abnormalities. Dis Nerv Syst. 1976, 37: 318-321.PubMed
22.
go back to reference Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V: Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis. Neurology. 1995, 45: 1340-1344.CrossRefPubMed Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V: Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis. Neurology. 1995, 45: 1340-1344.CrossRefPubMed
23.
go back to reference Sato Y, Honda Y, Asoh T, Kikuyama M, Oizumi K: Hypovitaminosis D and decreased bone mineral density in amyotrophic lateral sclerosis. Eur Neurol. 1997, 37: 225-229. 10.1159/000117447.CrossRefPubMed Sato Y, Honda Y, Asoh T, Kikuyama M, Oizumi K: Hypovitaminosis D and decreased bone mineral density in amyotrophic lateral sclerosis. Eur Neurol. 1997, 37: 225-229. 10.1159/000117447.CrossRefPubMed
24.
go back to reference Whitaker CH, Malchoff CD, Felice KJ: Treatable lower motor neuron disease due to vitamin D deficiency and secondary hyperparathyroidism. Amytroph Lateral Scler Other Motor Neuron Disord. 2000, 1: 283-286. 10.1080/14660820050515115.CrossRef Whitaker CH, Malchoff CD, Felice KJ: Treatable lower motor neuron disease due to vitamin D deficiency and secondary hyperparathyroidism. Amytroph Lateral Scler Other Motor Neuron Disord. 2000, 1: 283-286. 10.1080/14660820050515115.CrossRef
25.
go back to reference Patten BM, Bilezikian JP, Mallette LE, Prince A, Engel WK, Aurbach GD: Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med. 1974, 80: 182-193.CrossRefPubMed Patten BM, Bilezikian JP, Mallette LE, Prince A, Engel WK, Aurbach GD: Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med. 1974, 80: 182-193.CrossRefPubMed
26.
go back to reference Kaminski HJ, Ruff RL: Congenital disorders of neuromuscular transmission. Hosp Pract. 1992, 27: 73-81.CrossRef Kaminski HJ, Ruff RL: Congenital disorders of neuromuscular transmission. Hosp Pract. 1992, 27: 73-81.CrossRef
27.
go back to reference Frame B, Heinze EG, Block MA, Manson GA: Myopathy in primary hyperparathyroidism: observations in three patients. Ann Intern Med. 1968, 68: 1022-1027.CrossRefPubMed Frame B, Heinze EG, Block MA, Manson GA: Myopathy in primary hyperparathyroidism: observations in three patients. Ann Intern Med. 1968, 68: 1022-1027.CrossRefPubMed
29.
go back to reference Healton EB, Savage DG, Brust JC: Neurologic aspects of cobalamin deficiency. Medicine (Baltimore). 1991, 70: 229-245.CrossRef Healton EB, Savage DG, Brust JC: Neurologic aspects of cobalamin deficiency. Medicine (Baltimore). 1991, 70: 229-245.CrossRef
30.
go back to reference Kroliunitskaia T: On the treatment of patients with lateral amyotrophic sclerosis with vitamin B12. Zh Nevropatol Psikhiatr Im S S Korsakova. 1959, 59: 1447-1450.PubMed Kroliunitskaia T: On the treatment of patients with lateral amyotrophic sclerosis with vitamin B12. Zh Nevropatol Psikhiatr Im S S Korsakova. 1959, 59: 1447-1450.PubMed
Metadata
Title
Amyotrophic lateral sclerosis-motor neuron disease, monoclonal gammopathy, hyperparathyroidism, and B12 deficiency: case report and review of the literature
Authors
Richard A Rison
Said R Beydoun
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2010
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-4-298

Other articles of this Issue 1/2010

Journal of Medical Case Reports 1/2010 Go to the issue